The IPO Buzz: Red-Hot Bio-IPOs
The days of the biotech and biopharma companies are coming to Wall Street. Three of the six IPOs on this week’s calendar are bio-IPOs and eight – yes, eight – of next week’s 10 IPOs are bio-IPOs. The emergence of this industrial sector should not be surprising. It has been sizzling.